{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-001502","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.577635+00:00","generated_at":"2026-05-30T01:47:25.903445+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lifeloc Q3 2024 net loss $158K, revenue down 23% YoY; SpinDx progress","bullets":["Q3 net revenue $2.087M (down 23% YoY); net loss $158K ($0.06/diluted) vs prior year profit $110K.","Nine-month 2024 revenue $6.628M, net loss $740K ($0.30/diluted) vs prior year profit $111K.","Gross margin improved to 43.7% in Q3 vs 41.5% last year; nine-month 41.4% vs 43.4%.","SpinDx saliva THC detection system beta testing planned this quarter; commercial launch projected later in 2025.","Raised $750K line of credit and $798K private placement (210K shares at $3.80) to fund SpinDx development."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-001502","json":"https://secwatch.observer/filing/0001079973-24-001502.json","markdown":"https://secwatch.observer/filing/0001079973-24-001502.md","text":"https://secwatch.observer/filing/0001079973-24-001502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001502/0001079973-24-001502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001502/lctc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:47:25.903445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}